Johnson & Johnson (JNJ) : Net money flow in Johnson & Johnson (JNJ) was negative ($49.57 million) and the inflow of money on uptick was $88.73 million, whereas, the outflow of money on downticks amounted to $138.3 million on Tuesday. The traders used every opportunity of price strength in the stock to sell their positions, hence, the total uptick to downtick ratio was 0.64. The block trades show that the large investors, were aggressive sellers in the stock. The total value of block trades on upticks was only $10.69 million. On the other hand, the total value of block trades done on downticks was $61.45 million. The ratio of uptick to downtick block trades was 0.17. The money flow in block trades was negative ($50.76). Johnson & Johnson (JNJ) gained $0.88 cent during the day and reached $119.92, a gain of 0.74% over the previous day.
Also, Major Brokerage house, Jefferies maintains its ratings on Johnson & Johnson (NYSE:JNJ). In the latest research report, Jefferies raises the target price from $113 per share to $119 per share. According to the latest information available, the shares are now rated Hold by the analysts at the agency. The rating by the firm was issued on August 4, 2016.
Shares of Johnson & Johnson appreciated by 0.03% during the last five trading days but lost 4.09% on a 4-week basis. Johnson & Johnson is up 6.64% in the last 3-month period. Year-to-Date the stock performance stands at 18.77%.
Johnson & Johnson (NYSE:JNJ): The stock opened at $120.67 on Tuesday but the bulls could not build on the opening and the stock topped out at $120.67 for the day. The stock traded down to $119.26 during the day, due to lack of any buying support eventually closed down at $119.47 with a loss of -0.38% for the day. The stock had closed at $119.92 on the previous day. The total traded volume was 3,820,510 shares.
In a related news, Caruso Dominic J, officer (Exec VP, Finance; CFO) of Johnson & Johnson, unloaded 41,146 shares at an average price of $125.01 on July 26, 2016. The total amount of the transaction was worth $5,143,661, according to the disclosed information with the Securities and Exchange Commission in a Form 4 filing.
Johnson & Johnson is a holding company. The Company is engaged in the research and development, manufacture and sale of a range of products in the health care field. The Company has more than 265 operating companies conducting business around the world. The Companys primary focus is products related to human health and well-being. The Company is organized into three business segments: Consumer, Pharmaceutical and Medical Devices. The Companys subsidiaries operate 134 manufacturing facilities occupying approximately 21.5 million square feet of floor space. The Companys research facilities are located in the United States, Belgium, Brazil, Canada, China, France, Germany, India, Israel, Japan, the Netherlands, Singapore, Switzerland and the United Kingdom.